HealthStream
HSTM Nasdaq· Health Care Technology
Last close · Oct 23, 2026
$35.16
KIRA · Stoqly’s AI analyst, in plain words
- HealthStream had $304M of revenue in fiscal 2025, up 4.3% on the year before. Over five years, revenue changed +4.4% a year on average.
- Its operating margin was 6.7%, down 0.6 pts: of every 100 in sales, about 7 is left after running the business.
- HealthStream made $18.3M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew 19.8% a year.
- Free cash flow was $59.6M in fiscal 2025, 19.6% of revenue.
- HealthStream returned $33.8M to shareholders in fiscal 2025, 57% of free cash flow. The diluted share count fell 1.3%.
Market cap
$1.0B
P/E
48.8x
Revenue
$304M
Net income
$18.3M
Free cash flow
$59.6M
Operating margin
6.7%
HealthStream in 30 seconds · fiscal 2025
Are sales growing?
+4.3%
Only a little. Sales grew 4.3% last year.
Does it make a profit?
6.0%
A little. It keeps 6.0% of every sale as profit.
Does profit turn into cash?
19.6%
Yes. 19.6% of sales ends up as free cash.
How is the share priced?
48.8x
One share costs 48.8 times its yearly profit per share. Typical for its sector: 27.9x.
What HealthStream does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 27, 2026
- Legal name
- HEALTHSTREAM INC
- CIK
- 0001095565
HealthStream · HSTM
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $257M | $267M | $279M | $292M | $304M |
| Revenue growth | 4.9% | 3.9% | 4.6% | 4.5% | 4.3% |
| Operating margin | 3.1% | 4.7% | 5.7% | 7.3% | 6.7% |
| Net income | $5.8M | $12.1M | $15.2M | $20.0M | $18.3M |
| Net margin | 2.3% | 4.5% | 5.5% | 6.9% | 6.0% |
| Diluted EPS | $0.18 | $0.39 | $0.50 | $0.66 | $0.61 |
| Cash | |||||
| Cash from operations | $42.4M | $51.2M | $64.0M | $57.7M | $63.3M |
| Capital expenditure | $3.4M | $1.8M | $2.2M | $1.4M | $3.7M |
| Free cash flow | $39.0M | $49.4M | $61.8M | $56.3M | $59.6M |
| FCF margin | 15.2% | 18.5% | 22.1% | 19.3% | 19.6% |
| Dividends paid | $0.0M | $0.0M | $3.1M | $3.4M | $3.7M |
| Share buybacks | $5.0M | $23.1M | $8.9M | $0.0M | $30.0M |
| Share count change | −1.2% | −2.9% | −0.1% | −0.4% | −1.3% |
| Debt and strength | |||||
| Cash and short-term investments | $51.9M | $53.9M | $71.1M | $97.2M | $57.0M |
| Shareholders' equity | $339M | $334M | $341M | $359M | $354M |
| Current ratio | 1.1x | 1.0x | 1.1x | 1.3x | 1.0x |
| Interest coverage | 61.0x | 125.8x | 121.4x | 210.8x | 200.4x |
| Returns and quality | |||||
| Return on equity | 1.7% | 3.6% | 4.5% | 5.7% | 5.1% |
| Altman Z'' | 3.1 | 2.8 | 3.2 | 4.0 | 3.2 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$5.2M
5 insiders
Of sales under plans
13%
$0.7M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
HealthStream · HSTM
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| HealthStream HSTM | $1.0B | 4.3% | 6.7% | 19.6% | — | 48.8x | — |
| Certara CERT | $1.6B | 8.8% | 5.0% | 22.6% | 0.9% | — | 5 |
| Doximity DOCS | $6.4B | 13.1% | 33.3% | 50.6% | 91.3% | 39.3x | 4 |
| Veeva Systems VEEV | $52.5B | 16.3% | 28.7% | 43.4% | — | 52.1x | 6 |
| Solventum SOLV | $14.9B | 0.9% | 26.2% | −0.1% | 20.4% | 10.5x | 5 |
Price compared with profit (P/E)
How many times its yearly profit per share one share costs. Higher means investors pay more for each unit of profit.
KIRA
At $35.16 a share, the company is worth $1.0B: 48.8 times its earnings of the last four quarters.
HealthStream grew sales faster than 1 of its 4 similar companies. Its P/E is higher than 2 of 3.
Source: SEC EDGAR XBRL filings (CIK 0001095565). Data updated October 22, 2026. For information only — not investment advice. Check the original filings before relying on any figure.